*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Methoxy PEG Succinimidyl Succinate</strong> is a heterobifunctional PEG reagent featuring an activated NHS ester and a methoxy terminus. Its core synthesis involves reacting mPEG-NHS with succinic anhydride to introduce a carboxyl group for conjugation. The molecular formula is typically C<sub>n</sub>H<sub>2n+4</sub>O<sub>n+1</sub>NH, with CAS No. varying by MW.</p>
<h3>Application</h3>
<ul>
<li><strong>Peptide Modification:</strong> Conjugating PEG chains to therapeutic peptides to enhance solubility and reduce immunogenicity.</li>
<li><strong>Antibody Drug Conjugates (ADCs):</strong> Linking cytotoxic payloads to monoclonal antibodies via stable amide bonds.</li>
<li><strong>Protein Engineering:</strong> Modifying surface residues of enzymes to improve stability in industrial biocatalysis.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage:</strong> Keep under inert atmosphere at -20°C to prevent hydrolysis of the NHS ester.</li>
<li><strong>Safety:</strong> Handle in a fume hood; avoid skin contact as it acts as an alkylating agent.</li>
<li><strong>Limitation:</strong> Not for direct human administration; strictly for research or GMP manufacturing use only.</li>
</ul>